Determination of the Absorption, Metabolism, Excretion and Absolute Bioavailability of SCH 900777 in Healthy, Adult, Male Volunteers (P-05905).

Completed

• Conditions: 10027946; depression

• Registration Number: NL-OMON34835
• Lead Sponsor: Schering-Plough

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 6

Inclusion Criteria

male
18-55 years
BMI_ 19-30 kg/m2
non smoker or light smoker

Exclusion Criteria

Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months preceding the start of this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Criteria for evaluation:<br /><br>Pharmacokinetics<br /><br>Radiokinetics<br /><br>Safety<br /><br><br /><br>Statistical Methods:<br /><br>Pharmakinetics parameters : descriptive statistics<br /><br>Safety parameters : descriptive statistics</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>